<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-9C9RRLJP/6a86aa87-d4d9-4bbf-a831-f62984952958/HTML"><dcterms:extent>30 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-9C9RRLJP/950bcb2b-5ae9-4e8f-9cc2-4938bf42f27f/PDF"><dcterms:extent>73 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-9C9RRLJP/0f73949e-a577-4bab-8b36-998d7d267487/TEXT"><dcterms:extent>24 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-9C9RRLJP"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2001</dcterms:issued><dc:creator>Accetto, Rok</dc:creator><dc:creator>Dolenc, Primož</dc:creator><dc:creator>Žemva, Aleš</dc:creator><dc:format xml:lang="sl">številka:5</dc:format><dc:format xml:lang="sl">letnik:70</dc:format><dc:format xml:lang="sl">str. 279-283</dc:format><dc:identifier>COBISSID:13151449</dc:identifier><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-9C9RRLJP</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="en">Adverse effects</dc:subject><dc:subject xml:lang="en">Age factors</dc:subject><dc:subject xml:lang="en">Antihypertensive agents</dc:subject><dc:subject xml:lang="en">cardiovascular disease</dc:subject><dc:subject xml:lang="en">drug</dc:subject><dc:subject xml:lang="en">Drug therapy</dc:subject><dc:subject xml:lang="en">Drug therapy, combination</dc:subject><dc:subject xml:lang="sl">hipertenzija</dc:subject><dc:subject xml:lang="en">Hypertension</dc:subject><dc:subject xml:lang="sl">kardiovaskularne bolezni</dc:subject><dc:subject xml:lang="en">Questionnaires</dc:subject><dc:subject xml:lang="sl">stranski učinki</dc:subject><dc:subject xml:lang="en">Therapeutic use</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">zdravila</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Nadzor hipertenzije v republiki Sloveniji| Control of hypertension in the republic of Slovenia|</dc:title><dc:description xml:lang="sl">Background: It has been reported from many countries that blood pressure is well controlled (&lt; 130/85 and &lt; 140/90 after 65 years of age) in low percentage of hyperterzsive patients. The purpose of the study was to assess, how efficient we are in control of hypertension and to evaluate the tolerability of antihypertensive drugs in Slovenia. Methods. The data were obtained by means of a questionnaire. The survey was performed in January and February 1999 and 2244 hypertensive patients and 207 doctors participated in it. We were interested in the level of blood pressure, the drugs taken for hypertension and their adverse effects. Particular attention was paid to the action under taken by the doctor either in case of uncontrolled blood pressureor adverse side effects of the drugs. Results. In only 9.1% of patients blood pressure was well controlled. 22.2% of patients spontaneously reported adverse effects of the medication. If the patients were asked about adverse effects, 31.5% of patients confirmed the presence of these effects. Ifadverse effects were read from a list of symptoms, 63% of patients decided that they had one or more symptoms mentioned on the list. In 35.3 % of patients their doctor felt that these symptoms were really related to the antihypertensive medication. Treatment was adjusted or changed in 35% of patients with uncontrolled blood pressure and in 21 % of patients with adverseeffects. Conclusions. The study has demonstrated that the blood pressure control rate is low in our population. One of the reasons for that are adverse effects of anti hypertensive drugs. The study has shown a gap between patients' and physician's perception of adverse effects. Therefore, adherence to treatment can be improved by prescribing drugs with least adverseeffects</dc:description><dc:description xml:lang="sl">Izhodišča. Tuje izkušnje kažejo, da ima le majhen odstotek hipertonikov urejenkrvni tlak (&lt; 130/85 oziroma 140/90 za starejše od 65 let). Zato nas je zanimalo, kako učinkovito zdravimo hipertenzijo in kako bolniki zdravljenje prenašajo. Metode. Podatke smo zbrali s pomočjo ankete, v kateri je sodelovalo2244 bolnikov in 207 zdravnikov. Anketo smo izvajali januarja in februarja 1999. Zanimalo nas je, kakšen krvni tlak imajo bolniki, katera zdravila jemljejo, kakšne neželene učinke imajo ter kaj zdravnik ukrene, če ugotovi, da je krvni tlak previsok oziroma da ima bolnik neželene učinke zdravil. Rezultati. Ugotovili smo, da ima samo 9,1% hipertonikov primeren krvni tlak. O neželenih učinkih je spontano poročalo 22,2% bolnikov. Če so bili bolniki vprašani, ali so opazili kakšne neželene učinke, je pritrdilo 31,5% bolnikov. Ce so bili neželeni učinki zdravil bolnikom našteti s seznama,je 63% bolnikov menilo, da jih ima; ob tem je pri 35,3% bolnikov tudi zdravnik smatral, da gre dejansko za neželeni učinek zdravila in ne za simptom, ki ni povezan z zdravili. Zdravnik je prilagodil ali spremenil zdravljenje pri 35% bolnikov, če je bil krvni tlak previsok, in pri 2l% bolnikov zaradi neželenih učinkov. Zaključki: Ugotavljamo, da ima le majhen odstotek hipertenzivnih bolnikov urejen krvni tlak. Eden izmed vzrokov za to so neželeni učinki zdravil. Ob tem je zaznava neželenih učinkov pri bolniku inzdravniku precej različna. Bolnikovo zavzetost za zdravljenje hipertenzije lahko izboljšamo z zdravili, ki imajo čim manj neželenih učinkov</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-9C9RRLJP"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-9C9RRLJP" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-9C9RRLJP/950bcb2b-5ae9-4e8f-9cc2-4938bf42f27f/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-9C9RRLJP/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-9C9RRLJP" /></ore:Aggregation></rdf:RDF>